ERBB2 and breast carcinoma: Breast cancer patients were mainly diagnosed for an invasive carcinoma of no specific type (76%), clinical stage I (84%), with a good prognostic grade (20% of grades I and 64% grade II), 100% being ER/Pg+ and HER2- (Table 2).